Please login to the form below

Not currently logged in
Email:
Password:

influenza

This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.

Pfizer signs $425m flu vaccine deal with Germany’s BioNTech

Pfizer signs $425m flu vaccine deal with Germany’s BioNTech

Pfizer has teamed up with German biotech BioNTech to develop a new generation of influenza vaccines that can be made quicker and more cheaply than current products. ... New flu vaccines are needed to provide improved protection against seasonal flu, and

Latest news

More from news
Approximately 20 fully matching, plus 197 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2016 Deal Watch February 2016

    coli and influenza, and in toxicology applications. While Abbott already has a significant diagnostics presence with global sales in 2015 in this segment of $4.6bn, it forecasts that the acquisition

  • Another lost decade for research? Another lost decade for research?

    diseases that cause significant morbidity and mortality, such as influenza and malaria, but remain difficult to vaccinate against.

  • Pharma deals in June 2015 Pharma deals in June 2015

    85. BioCryst Pharmaceuticals/ CSL. RAPIVAB (peramivir injection) for the treatment of influenza (marketed).

  • Wearables: the tangible product of the patient revolution Wearables: the tangible product of the patient revolution

    The opportunity is massive - in the public health arena, there exists the possibility that outbreaks of diseases such as Ebola or influenza could be seen and stopped before they become critical.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    318. Novartis/CSL. Asset purchase. Influenza vaccines. 275. Five Prime/GSK. Expansion of collaboration.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.

  • Influenza

    Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1) which produces rapidly-updated heatmaps of illness across the country.

More from PMHub
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics